Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

Background: Behçet's disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20–50% of the involved eyes within 5 years. The efficacy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kötter, I, Zierhut, M, Eckstein, A K, Vonthein, R, Ness, T, Günaydin, I, Grimbacher, B, Blaschke, S, Meyer-Riemann, W, Peter, H H, Stübiger, N
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Copyright 2003 British Journal of Ophthalmology 2003
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1771623/
https://ncbi.nlm.nih.gov/pubmed/12642304
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak